GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Bangkok Lab and Cosmetic PCL (BKK:BLC) » Definitions » EV-to-EBITDA

Bangkok Lab and Cosmetic PCL (BKK:BLC) EV-to-EBITDA : 10.27 (As of May. 11, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Bangkok Lab and Cosmetic PCL EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Bangkok Lab and Cosmetic PCL's enterprise value is ฿2,599 Mil. Bangkok Lab and Cosmetic PCL's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was ฿253 Mil. Therefore, Bangkok Lab and Cosmetic PCL's EV-to-EBITDA for today is 10.27.

The historical rank and industry rank for Bangkok Lab and Cosmetic PCL's EV-to-EBITDA or its related term are showing as below:

BKK:BLC' s EV-to-EBITDA Range Over the Past 10 Years
Min: 7.26   Med: 8.92   Max: 21.3
Current: 10.27

During the past 3 years, the highest EV-to-EBITDA of Bangkok Lab and Cosmetic PCL was 21.30. The lowest was 7.26. And the median was 8.92.

BKK:BLC's EV-to-EBITDA is ranked better than
53.35% of 1537 companies
in the Consumer Packaged Goods industry
Industry Median: 10.99 vs BKK:BLC: 10.27

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-11), Bangkok Lab and Cosmetic PCL's stock price is ฿5.40. Bangkok Lab and Cosmetic PCL's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was ฿0.250. Therefore, Bangkok Lab and Cosmetic PCL's PE Ratio for today is 21.60.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Bangkok Lab and Cosmetic PCL EV-to-EBITDA Historical Data

The historical data trend for Bangkok Lab and Cosmetic PCL's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bangkok Lab and Cosmetic PCL EV-to-EBITDA Chart

Bangkok Lab and Cosmetic PCL Annual Data
Trend Dec21 Dec22 Dec23
EV-to-EBITDA
- - 8.45

Bangkok Lab and Cosmetic PCL Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only - - 13.18 9.77 8.45

Competitive Comparison of Bangkok Lab and Cosmetic PCL's EV-to-EBITDA

For the Household & Personal Products subindustry, Bangkok Lab and Cosmetic PCL's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bangkok Lab and Cosmetic PCL's EV-to-EBITDA Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Bangkok Lab and Cosmetic PCL's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Bangkok Lab and Cosmetic PCL's EV-to-EBITDA falls into.



Bangkok Lab and Cosmetic PCL EV-to-EBITDA Calculation

Bangkok Lab and Cosmetic PCL's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=2598.805/253.074
=10.27

Bangkok Lab and Cosmetic PCL's current Enterprise Value is ฿2,599 Mil.
Bangkok Lab and Cosmetic PCL's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿253 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bangkok Lab and Cosmetic PCL  (BKK:BLC) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Bangkok Lab and Cosmetic PCL's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=5.40/0.250
=21.60

Bangkok Lab and Cosmetic PCL's share price for today is ฿5.40.
Bangkok Lab and Cosmetic PCL's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿0.250.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Bangkok Lab and Cosmetic PCL EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Bangkok Lab and Cosmetic PCL's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Bangkok Lab and Cosmetic PCL (BKK:BLC) Business Description

Traded in Other Exchanges
N/A
Address
Nong Chae Sao Road, No. 48/1 Moo 5, Nam Phu, Mueang Ratchaburi, Ratchaburi, Bangkok, THA, 70000
Bangkok Lab and Cosmetic PCL are one of Thailand's comprehensive healthcare solutions groups. Its operation covers the complete value chain of the healthcare business. Its product portfolio comprises generic and new generic drugs, herbal medicines, animal medicines, cosmetics, food supplements, and other health products. Its operation ranges from research and development, manufacturing with international standards, sales, and marketing, to distribution to partnering businesses and customers.

Bangkok Lab and Cosmetic PCL (BKK:BLC) Headlines

No Headlines